{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Eagle\u2019s Eye View:\u202fTop 2025 ACC Content \u202f ","description":" In this episode, Dr. Eagle looks&amp;nbsp;back&amp;nbsp;at&amp;nbsp;2025 and explores some of the significant developments that show how the College is responding to changes in the way we evaluate, manage, and follow patients with&amp;nbsp;various types&amp;nbsp;of cardiovascular disorders.&amp;nbsp;His&amp;nbsp;survey of&amp;nbsp;topics&amp;nbsp;that received the most attention&amp;nbsp;include&amp;nbsp;the new guidelines on hypertension, acute coronary syndromes, the management of adults with congenital heart disease, cardiogenic shock, pericarditis, sports cardiology,&amp;nbsp;weight management, amyloid heart&amp;nbsp;disease&amp;nbsp;and inflammation.&amp;nbsp;Last year's&amp;nbsp;most popular articles include insights into SGLT-2 inhibitors in patients with&amp;nbsp;heart failure&amp;nbsp;with reduced ejection fraction&amp;nbsp;(HFrEF), flu vaccines, anticoagulation, and much more&amp;nbsp;impacting&amp;nbsp;the changing landscape of cardiology.&amp;nbsp;\u202f\u202f\u202f&amp;nbsp;   \u202fSubscribe to Eagle\u2019s Eye View\u202f\u202f&amp;nbsp;  ","author_name":"Eagle's Eye View: Your Weekly CV Update From ACC.org","author_url":"http:\/\/www.acc.org","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/39629510\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/197203255"}